Uric acid induces NADPH oxidase-independent neutrophil extracellular trap formation |
| |
Authors: | Yasuyuki Arai Yoko Nishinaka Toshiyuki Arai Makiko Morita Kiyomi Mizugishi Souichi Adachi Akifumi Takaori-Kondo Tomohiro Watanabe Kouhei Yamashita |
| |
Affiliation: | 1. Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan;2. Human Health Science, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan;3. Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan;4. Department of Anesthesia, Kyoto City Hospital, Kyoto 604-8845, Japan;5. Center for Innovation in Immunoregulative Technology and Therapeutics, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan |
| |
Abstract: | Neutrophil extracellular traps (NETs) are composed of extracellular DNA fibers with antimicrobial peptides that capture and kill microbes. NETs play a critical role in innate host defense and in autoimmune and inflammatory diseases. While the mechanism of NET formation remains unclear, reactive oxygen species (ROS) produced via activation of NADPH oxidase (Nox) are known to be an important requirement. In this study, we investigated the effect of uric acid (UA) on NET formation. UA, a well-known ROS scavenger, was found to suppress Nox-dependent ROS release in a dose-dependent manner. Low concentrations of UA significantly inhibited Nox-dependent NET formation. However, high concentrations of UA unexpectedly induced, rather than inhibited, NET formation. NETs were directly induced by UA alone in a Nox-independent manner, as revealed by experiments using control neutrophils treated with ROS inhibitors or neutrophils of patients with chronic granulomatous disease who have a congenital defect in ROS production. Furthermore, we found that UA-induced NET formation was partially mediated by NF-κB activation. Our study is the first to demonstrate the novel function of UA in NET formation and may provide insight into the management of patients with hyperuricemia. |
| |
Keywords: | CGD, chronic granulomatous disease DHR, dihydrorhodamine 123 DPI, diphenyleneiodonium HBSS, Hanks&rsquo balanced salt solution MSU, monosodium urate MVP, trans-1-(2&prime -methoxyvinyl)pyrene Nox, NADPH oxidase NET, neutrophil extracellular trap PBN, α-phenyl-N-tert-butyl nitrone PMA, phorbol myristate acetate ROS, reactive oxygen species 1O2, singlet oxygen UA, uric acid |
本文献已被 ScienceDirect 等数据库收录! |
|